Industry Research Reports
Home > Reports > Medical Devices & Consumables > Congestive Heart Failure (CHF) Treatment Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Congestive Heart Failure (CHF) Treatment Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Congestive Heart Failure (CHF) Treatment Devices Market Size(US$)
CAGR 2026-2032
3.1%
Market Size,2032
USD 6,918
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 5,760 million
Market Forecast in 2032(Value)
US$ 6,918 million
CAGR
3.1%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Congestive Heart Failure (CHF) Treatment Devices was estimated to be worth US$ 5603 million in 2025 and is projected to reach US$ 6918 million, growing at a CAGR of 3.1% from 2026 to 2032.
Congestive heart failure (CHF) is a physiological condition that has an adverse impact on the pumping efficiency of the cardiac muscles. It characterizes the accumulation of fluid around the heart leading to inefficient pumping. The onset of CHF is marked by the failure of the ventricles to pump sufficient volume of blood to the body organs. This eventually leads to deposition of fluid in the lungs, abdomen, liver, and lower body. CHF is treated by a number of devices that maintain heart rhythm, such as pacemakers, cardiac resynchronization therapy (CRT), implantable cardioverter defibrillators (ICDs), and ventricular assist devices (VADs).
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report provides a comprehensive view of the global market for Congestive Heart Failure (CHF) Treatment Devices, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Congestive Heart Failure (CHF) Treatment Devices market size, estimations, and forecasts are presented in terms of sales volume (K Units) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Congestive Heart Failure (CHF) Treatment Devices.
Market Segmentation
By Company
- Abiomed
- Berlin Heart GmbH
- Biotronik SE & Co. KG
- Boston Scientific Corporation
- HeartWare International
- Jarvik Heart
- LivaNova PLC
- Medtronic
- ReliantHeart
- Abbott
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Cardiac Resynchronization Therapy (CRT)
- Implantable Cardioverter Defibrillators (ICDs)
Segment by Application
- Left Ventricular Assist Device (LVAD)
- Right Ventricular Assist Device (RVAD)
- Biventricular Assist Device (BIVAD)
Chapter Outline
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Congestive Heart Failure (CHF) Treatment Devices manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Congestive Heart Failure (CHF) Treatment Devices sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Congestive Heart Failure (CHF) Treatment Devices sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
Table of Contents
1 Market Overview
1.1 Congestive Heart Failure (CHF) Treatment Devices Product Introduction
1.2 Global Congestive Heart Failure (CHF) Treatment Devices Market Size Forecast
1.2.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales Value (2021–2032)
1.2.2 Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume (2021–2032)
1.2.3 Global Congestive Heart Failure (CHF) Treatment Devices Sales Price (2021–2032)
1.3 Congestive Heart Failure (CHF) Treatment Devices Market Trends & Drivers
1.3.1 Congestive Heart Failure (CHF) Treatment Devices Industry Trends
1.3.2 Congestive Heart Failure (CHF) Treatment Devices Market Drivers & Opportunities
1.3.3 Congestive Heart Failure (CHF) Treatment Devices Market Challenges
1.3.4 Congestive Heart Failure (CHF) Treatment Devices Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Congestive Heart Failure (CHF) Treatment Devices Players Revenue Ranking (2025)
2.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Company (2021–2026)
2.3 Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume Ranking of Players (2025)
2.4 Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume by Company (2021–2026)
2.5 Global Congestive Heart Failure (CHF) Treatment Devices Average Price by Company (2021–2026)
2.6 Key Manufacturers Congestive Heart Failure (CHF) Treatment Devices Manufacturing Base and Headquarters
2.7 Key Manufacturers Congestive Heart Failure (CHF) Treatment Devices Product Offerings
2.8 Key Manufacturers Start of Mass Production of Congestive Heart Failure (CHF) Treatment Devices
2.9 Congestive Heart Failure (CHF) Treatment Devices Market Competitive Analysis
2.9.1 Congestive Heart Failure (CHF) Treatment Devices Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Congestive Heart Failure (CHF) Treatment Devices Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Congestive Heart Failure (CHF) Treatment Devices revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Congestive Heart Failure (CHF) Treatment Devices Market Classification
3.1 Introduction by Type
3.1.1 Cardiac Resynchronization Therapy (CRT)
3.1.2 Implantable Cardioverter Defibrillators (ICDs)
3.1.3 Global Congestive Heart Failure (CHF) Treatment Devices Sales Value by Type
3.1.3.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales Value by Type (2021 vs 2025 vs 2032)
3.1.3.2 Global Congestive Heart Failure (CHF) Treatment Devices Sales Value, by Type (2021–2032)
3.1.3.3 Global Congestive Heart Failure (CHF) Treatment Devices Sales Value, by Type (%), 2021–2032
3.1.4 Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume by Type
3.1.4.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume, by Type (2021–2032)
3.1.4.3 Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume, by Type (%), 2021–2032
3.1.5 Global Congestive Heart Failure (CHF) Treatment Devices Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Left Ventricular Assist Device (LVAD)
4.1.2 Right Ventricular Assist Device (RVAD)
4.1.3 Biventricular Assist Device (BIVAD)
4.2 Global Congestive Heart Failure (CHF) Treatment Devices Sales Value by Application
4.2.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Congestive Heart Failure (CHF) Treatment Devices Sales Value, by Application (2021–2032)
4.2.3 Global Congestive Heart Failure (CHF) Treatment Devices Sales Value, by Application (%), 2021–2032
4.3 Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume by Application
4.3.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume, by Application (2021–2032)
4.3.3 Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume, by Application (%), 2021–2032
4.4 Global Congestive Heart Failure (CHF) Treatment Devices Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales Value by Region
5.1.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Congestive Heart Failure (CHF) Treatment Devices Sales Value by Region (2021–2026)
5.1.3 Global Congestive Heart Failure (CHF) Treatment Devices Sales Value by Region (2027–2032)
5.1.4 Global Congestive Heart Failure (CHF) Treatment Devices Sales Value by Region (%), 2021–2032
5.2 Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume by Region
5.2.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume by Region (2021–2026)
5.2.3 Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume by Region (2027–2032)
5.2.4 Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume by Region (%), 2021–2032
5.3 Global Congestive Heart Failure (CHF) Treatment Devices Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Congestive Heart Failure (CHF) Treatment Devices Sales Value, 2021–2032
5.4.2 North America Congestive Heart Failure (CHF) Treatment Devices Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Congestive Heart Failure (CHF) Treatment Devices Sales Value, 2021–2032
5.5.2 Europe Congestive Heart Failure (CHF) Treatment Devices Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Sales Value, 2021–2032
5.6.2 Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Congestive Heart Failure (CHF) Treatment Devices Sales Value, 2021–2032
5.7.2 South America Congestive Heart Failure (CHF) Treatment Devices Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Sales Value, 2021–2032
5.8.2 Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Congestive Heart Failure (CHF) Treatment Devices Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Congestive Heart Failure (CHF) Treatment Devices Sales Value and Sales Volume
6.2.1 Key Countries/Regions Congestive Heart Failure (CHF) Treatment Devices Sales Value, 2021–2032
6.2.2 Key Countries/Regions Congestive Heart Failure (CHF) Treatment Devices Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Congestive Heart Failure (CHF) Treatment Devices Sales Value, 2021–2032
6.3.2 United States Congestive Heart Failure (CHF) Treatment Devices Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Congestive Heart Failure (CHF) Treatment Devices Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Congestive Heart Failure (CHF) Treatment Devices Sales Value, 2021–2032
6.4.2 Europe Congestive Heart Failure (CHF) Treatment Devices Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Congestive Heart Failure (CHF) Treatment Devices Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Congestive Heart Failure (CHF) Treatment Devices Sales Value, 2021–2032
6.5.2 China Congestive Heart Failure (CHF) Treatment Devices Sales Value by Type (%), 2025 vs 2032
6.5.3 China Congestive Heart Failure (CHF) Treatment Devices Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Congestive Heart Failure (CHF) Treatment Devices Sales Value, 2021–2032
6.6.2 Japan Congestive Heart Failure (CHF) Treatment Devices Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Congestive Heart Failure (CHF) Treatment Devices Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Congestive Heart Failure (CHF) Treatment Devices Sales Value, 2021–2032
6.7.2 South Korea Congestive Heart Failure (CHF) Treatment Devices Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Congestive Heart Failure (CHF) Treatment Devices Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Congestive Heart Failure (CHF) Treatment Devices Sales Value, 2021–2032
6.8.2 Southeast Asia Congestive Heart Failure (CHF) Treatment Devices Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Congestive Heart Failure (CHF) Treatment Devices Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Congestive Heart Failure (CHF) Treatment Devices Sales Value, 2021–2032
6.9.2 India Congestive Heart Failure (CHF) Treatment Devices Sales Value by Type (%), 2025 vs 2032
6.9.3 India Congestive Heart Failure (CHF) Treatment Devices Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Abiomed
7.1.1 Abiomed Company Information
7.1.2 Abiomed Introduction and Business Overview
7.1.3 Abiomed Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 Abiomed Congestive Heart Failure (CHF) Treatment Devices Product Offerings
7.1.5 Abiomed Recent Developments
7.2 Berlin Heart GmbH
7.2.1 Berlin Heart GmbH Company Information
7.2.2 Berlin Heart GmbH Introduction and Business Overview
7.2.3 Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Product Offerings
7.2.5 Berlin Heart GmbH Recent Developments
7.3 Biotronik SE & Co. KG
7.3.1 Biotronik SE & Co. KG Company Information
7.3.2 Biotronik SE & Co. KG Introduction and Business Overview
7.3.3 Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Product Offerings
7.3.5 Biotronik SE & Co. KG Recent Developments
7.4 Boston Scientific Corporation
7.4.1 Boston Scientific Corporation Company Information
7.4.2 Boston Scientific Corporation Introduction and Business Overview
7.4.3 Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Product Offerings
7.4.5 Boston Scientific Corporation Recent Developments
7.5 HeartWare International
7.5.1 HeartWare International Company Information
7.5.2 HeartWare International Introduction and Business Overview
7.5.3 HeartWare International Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 HeartWare International Congestive Heart Failure (CHF) Treatment Devices Product Offerings
7.5.5 HeartWare International Recent Developments
7.6 Jarvik Heart
7.6.1 Jarvik Heart Company Information
7.6.2 Jarvik Heart Introduction and Business Overview
7.6.3 Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Product Offerings
7.6.5 Jarvik Heart Recent Developments
7.7 LivaNova PLC
7.7.1 LivaNova PLC Company Information
7.7.2 LivaNova PLC Introduction and Business Overview
7.7.3 LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Product Offerings
7.7.5 LivaNova PLC Recent Developments
7.8 Medtronic
7.8.1 Medtronic Company Information
7.8.2 Medtronic Introduction and Business Overview
7.8.3 Medtronic Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 Medtronic Congestive Heart Failure (CHF) Treatment Devices Product Offerings
7.8.5 Medtronic Recent Developments
7.9 ReliantHeart
7.9.1 ReliantHeart Company Information
7.9.2 ReliantHeart Introduction and Business Overview
7.9.3 ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue, Price and Gross Margin (2021–2026)
7.9.4 ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Product Offerings
7.9.5 ReliantHeart Recent Developments
7.10 Abbott
7.10.1 Abbott Company Information
7.10.2 Abbott Introduction and Business Overview
7.10.3 Abbott Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue, Price and Gross Margin (2021–2026)
7.10.4 Abbott Congestive Heart Failure (CHF) Treatment Devices Product Offerings
7.10.5 Abbott Recent Developments
8 Industry Chain Analysis
8.1 Congestive Heart Failure (CHF) Treatment Devices Industrial Chain
8.2 Congestive Heart Failure (CHF) Treatment Devices Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Congestive Heart Failure (CHF) Treatment Devices Sales Model
8.5.2 Sales Channels
8.5.3 Congestive Heart Failure (CHF) Treatment Devices Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. Congestive Heart Failure (CHF) Treatment Devices Market Trends
Table 2. Congestive Heart Failure (CHF) Treatment Devices Market Drivers & Opportunities
Table 3. Congestive Heart Failure (CHF) Treatment Devices Market Challenges
Table 4. Congestive Heart Failure (CHF) Treatment Devices Market Restraints
Table 5. Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Company (US$ Million), 2021–2026
Table 6. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Company (2021–2026)
Table 7. Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume by Company (K Units), 2021–2026
Table 8. Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume Market Share by Company (2021–2026)
Table 9. Global Market Congestive Heart Failure (CHF) Treatment Devices Price by Company (USD/Unit), 2021–2026
Table 10. Key Manufacturers Congestive Heart Failure (CHF) Treatment Devices Manufacturing Base and Headquarters
Table 11. Key Manufacturers Congestive Heart Failure (CHF) Treatment Devices Product Type
Table 12. Key Manufacturers Start of Mass Production of Congestive Heart Failure (CHF) Treatment Devices
Table 13. Global Congestive Heart Failure (CHF) Treatment Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Tier (Tier 1, Tier 2, Tier 3), based on Congestive Heart Failure (CHF) Treatment Devices revenue, 2025
Table 15. Mergers & Acquisitions and Expansion Plans
Table 16. Global Congestive Heart Failure (CHF) Treatment Devices Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)
Table 17. Global Congestive Heart Failure (CHF) Treatment Devices Sales Value by Type (US$ Million), 2021–2026
Table 18. Global Congestive Heart Failure (CHF) Treatment Devices Sales Value by Type (US$ Million), 2027–2032
Table 19. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Value by Type (2021–2026)
Table 20. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Value by Type (2027–2032)
Table 21. Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume by Type: 2021 vs 2025 vs 2032 (K Units)
Table 22. Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume by Type (K Units), 2021–2026
Table 23. Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume by Type (K Units), 2027–2032
Table 24. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Volume by Type (2021–2026)
Table 25. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Volume by Type (2027–2032)
Table 26. Global Congestive Heart Failure (CHF) Treatment Devices Price by Type (USD/Unit), 2021–2026
Table 27. Global Congestive Heart Failure (CHF) Treatment Devices Price by Type (USD/Unit), 2027–2032
Table 28. Global Congestive Heart Failure (CHF) Treatment Devices Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)
Table 29. Global Congestive Heart Failure (CHF) Treatment Devices Sales Value by Application (US$ Million), 2021–2026
Table 30. Global Congestive Heart Failure (CHF) Treatment Devices Sales Value by Application (US$ Million), 2027–2032
Table 31. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Value by Application (2021–2026)
Table 32. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Value by Application (2027–2032)
Table 33. Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume by Application: 2021 vs 2025 vs 2032 (K Units)
Table 34. Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume by Application (K Units), 2021–2026
Table 35. Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume by Application (K Units), 2027–2032
Table 36. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Volume by Application (2021–2026)
Table 37. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Volume by Application (2027–2032)
Table 38. Global Congestive Heart Failure (CHF) Treatment Devices Price by Application (USD/Unit), 2021–2026
Table 39. Global Congestive Heart Failure (CHF) Treatment Devices Price by Application (USD/Unit), 2027–2032
Table 40. Global Congestive Heart Failure (CHF) Treatment Devices Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032
Table 41. Global Congestive Heart Failure (CHF) Treatment Devices Sales Value by Region (US$ Million), 2021–2026
Table 42. Global Congestive Heart Failure (CHF) Treatment Devices Sales Value by Region (US$ Million), 2027–2032
Table 43. Global Congestive Heart Failure (CHF) Treatment Devices Sales Value by Region (%), 2021–2026
Table 44. Global Congestive Heart Failure (CHF) Treatment Devices Sales Value by Region (%), 2027–2032
Table 45. Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume by Region (K Units): 2021 vs 2025 vs 2032
Table 46. Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume by Region (K Units), 2021–2026
Table 47. Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume by Region (K Units), 2027–2032
Table 48. Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume by Region (%), 2021–2026
Table 49. Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume by Region (%), 2027–2032
Table 50. Global Congestive Heart Failure (CHF) Treatment Devices Average Price by Region (USD/Unit), 2021–2026
Table 51. Global Congestive Heart Failure (CHF) Treatment Devices Average Price by Region (USD/Unit), 2027–2032
Table 52. Key Countries/Regions Congestive Heart Failure (CHF) Treatment Devices Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032
Table 53. Key Countries/Regions Congestive Heart Failure (CHF) Treatment Devices Sales Value, (US$ Million), 2021–2026
Table 54. Key Countries/Regions Congestive Heart Failure (CHF) Treatment Devices Sales Value, (US$ Million), 2027–2032
Table 55. Key Countries/Regions Congestive Heart Failure (CHF) Treatment Devices Sales Volume, (K Units), 2021–2026
Table 56. Key Countries/Regions Congestive Heart Failure (CHF) Treatment Devices Sales Volume, (K Units), 2027–2032
Table 57. Abiomed Company Information
Table 58. Abiomed Introduction and Business Overview
Table 59. Abiomed Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021–2026)
Table 60. Abiomed Congestive Heart Failure (CHF) Treatment Devices Product Offerings
Table 61. Abiomed Recent Developments
Table 62. Berlin Heart GmbH Company Information
Table 63. Berlin Heart GmbH Introduction and Business Overview
Table 64. Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021–2026)
Table 65. Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Product Offerings
Table 66. Berlin Heart GmbH Recent Developments
Table 67. Biotronik SE & Co. KG Company Information
Table 68. Biotronik SE & Co. KG Introduction and Business Overview
Table 69. Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021–2026)
Table 70. Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Product Offerings
Table 71. Biotronik SE & Co. KG Recent Developments
Table 72. Boston Scientific Corporation Company Information
Table 73. Boston Scientific Corporation Introduction and Business Overview
Table 74. Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021–2026)
Table 75. Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Product Offerings
Table 76. Boston Scientific Corporation Recent Developments
Table 77. HeartWare International Company Information
Table 78. HeartWare International Introduction and Business Overview
Table 79. HeartWare International Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021–2026)
Table 80. HeartWare International Congestive Heart Failure (CHF) Treatment Devices Product Offerings
Table 81. HeartWare International Recent Developments
Table 82. Jarvik Heart Company Information
Table 83. Jarvik Heart Introduction and Business Overview
Table 84. Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021–2026)
Table 85. Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Product Offerings
Table 86. Jarvik Heart Recent Developments
Table 87. LivaNova PLC Company Information
Table 88. LivaNova PLC Introduction and Business Overview
Table 89. LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021–2026)
Table 90. LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Product Offerings
Table 91. LivaNova PLC Recent Developments
Table 92. Medtronic Company Information
Table 93. Medtronic Introduction and Business Overview
Table 94. Medtronic Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021–2026)
Table 95. Medtronic Congestive Heart Failure (CHF) Treatment Devices Product Offerings
Table 96. Medtronic Recent Developments
Table 97. ReliantHeart Company Information
Table 98. ReliantHeart Introduction and Business Overview
Table 99. ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021–2026)
Table 100. ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Product Offerings
Table 101. ReliantHeart Recent Developments
Table 102. Abbott Company Information
Table 103. Abbott Introduction and Business Overview
Table 104. Abbott Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021–2026)
Table 105. Abbott Congestive Heart Failure (CHF) Treatment Devices Product Offerings
Table 106. Abbott Recent Developments
Table 107. Key Raw Materials Lists
Table 108. Key Suppliers of Raw Materials Lists
Table 109. Congestive Heart Failure (CHF) Treatment Devices Downstream Customers
Table 110. Congestive Heart Failure (CHF) Treatment Devices Distributors List
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Congestive Heart Failure (CHF) Treatment Devices Product Picture
Figure 2. Global Congestive Heart Failure (CHF) Treatment Devices Sales Value, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Global Congestive Heart Failure (CHF) Treatment Devices Sales Value (US$ Million), 2021–2032
Figure 4. Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume (K Units), 2021–2032
Figure 5. Global Congestive Heart Failure (CHF) Treatment Devices Sales Price (USD/Unit), 2021–2032
Figure 6. Congestive Heart Failure (CHF) Treatment Devices Report Years Considered
Figure 7. Global Congestive Heart Failure (CHF) Treatment Devices Players Revenue Ranking (US$ Million), 2025
Figure 8. Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume Ranking of Players (K Units), 2025
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Congestive Heart Failure (CHF) Treatment Devices Revenue in 2025
Figure 10. Congestive Heart Failure (CHF) Treatment Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 11. Cardiac Resynchronization Therapy (CRT) Picture
Figure 12. Implantable Cardioverter Defibrillators (ICDs) Picture
Figure 13. Global Congestive Heart Failure (CHF) Treatment Devices Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Congestive Heart Failure (CHF) Treatment Devices Sales Value Market Share by Type, 2025 & 2032
Figure 15. Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume by Type (K Units), 2021 vs 2025 vs 2032
Figure 16. Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume Market Share by Type, 2025 & 2032
Figure 17. Global Congestive Heart Failure (CHF) Treatment Devices Price by Type (USD/Unit), 2021–2032
Figure 18. Product Picture of Left Ventricular Assist Device (LVAD)
Figure 19. Product Picture of Right Ventricular Assist Device (RVAD)
Figure 20. Product Picture of Biventricular Assist Device (BIVAD)
Figure 21. Global Congestive Heart Failure (CHF) Treatment Devices Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032
Figure 22. Global Congestive Heart Failure (CHF) Treatment Devices Sales Value Market Share by Application, 2025 & 2032
Figure 23. Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume by Application (K Units), 2021 vs 2025 vs 2032
Figure 24. Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume Market Share by Application, 2025 & 2032
Figure 25. Global Congestive Heart Failure (CHF) Treatment Devices Price by Application (USD/Unit), 2021–2032
Figure 26. North America Congestive Heart Failure (CHF) Treatment Devices Sales Value (US$ Million), 2021–2032
Figure 27. North America Congestive Heart Failure (CHF) Treatment Devices Sales Value by Country (%), 2025 vs 2032
Figure 28. Europe Congestive Heart Failure (CHF) Treatment Devices Sales Value (US$ Million), 2021–2032
Figure 29. Europe Congestive Heart Failure (CHF) Treatment Devices Sales Value by Country (%), 2025 vs 2032
Figure 30. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Sales Value (US$ Million), 2021–2032
Figure 31. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Sales Value by Region (%), 2025 vs 2032
Figure 32. South America Congestive Heart Failure (CHF) Treatment Devices Sales Value (US$ Million), 2021–2032
Figure 33. South America Congestive Heart Failure (CHF) Treatment Devices Sales Value by Country (%), 2025 vs 2032
Figure 34. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Sales Value (US$ Million), 2021–2032
Figure 35. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Sales Value by Country (%), 2025 vs 2032
Figure 36. Key Countries/Regions Congestive Heart Failure (CHF) Treatment Devices Sales Value (%), 2021–2032
Figure 37. Key Countries/Regions Congestive Heart Failure (CHF) Treatment Devices Sales Volume (%), 2021–2032
Figure 38. United States Congestive Heart Failure (CHF) Treatment Devices Sales Value (US$ Million), 2021–2032
Figure 39. United States Congestive Heart Failure (CHF) Treatment Devices Sales Value by Type (%), 2025 vs 2032
Figure 40. United States Congestive Heart Failure (CHF) Treatment Devices Sales Value by Application (%), 2025 vs 2032
Figure 41. Europe Congestive Heart Failure (CHF) Treatment Devices Sales Value (US$ Million), 2021–2032
Figure 42. Europe Congestive Heart Failure (CHF) Treatment Devices Sales Value by Type (%), 2025 vs 2032
Figure 43. Europe Congestive Heart Failure (CHF) Treatment Devices Sales Value by Application (%), 2025 vs 2032
Figure 44. China Congestive Heart Failure (CHF) Treatment Devices Sales Value (US$ Million), 2021–2032
Figure 45. China Congestive Heart Failure (CHF) Treatment Devices Sales Value by Type (%), 2025 vs 2032
Figure 46. China Congestive Heart Failure (CHF) Treatment Devices Sales Value by Application (%), 2025 vs 2032
Figure 47. Japan Congestive Heart Failure (CHF) Treatment Devices Sales Value (US$ Million), 2021–2032
Figure 48. Japan Congestive Heart Failure (CHF) Treatment Devices Sales Value by Type (%), 2025 vs 2032
Figure 49. Japan Congestive Heart Failure (CHF) Treatment Devices Sales Value by Application (%), 2025 vs 2032
Figure 50. South Korea Congestive Heart Failure (CHF) Treatment Devices Sales Value (US$ Million), 2021–2032
Figure 51. South Korea Congestive Heart Failure (CHF) Treatment Devices Sales Value by Type (%), 2025 vs 2032
Figure 52. South Korea Congestive Heart Failure (CHF) Treatment Devices Sales Value by Application (%), 2025 vs 2032
Figure 53. Southeast Asia Congestive Heart Failure (CHF) Treatment Devices Sales Value (US$ Million), 2021–2032
Figure 54. Southeast Asia Congestive Heart Failure (CHF) Treatment Devices Sales Value by Type (%), 2025 vs 2032
Figure 55. Southeast Asia Congestive Heart Failure (CHF) Treatment Devices Sales Value by Application (%), 2025 vs 2032
Figure 56. India Congestive Heart Failure (CHF) Treatment Devices Sales Value (US$ Million), 2021–2032
Figure 57. India Congestive Heart Failure (CHF) Treatment Devices Sales Value by Type (%), 2025 vs 2032
Figure 58. India Congestive Heart Failure (CHF) Treatment Devices Sales Value by Application (%), 2025 vs 2032
Figure 59. Congestive Heart Failure (CHF) Treatment Devices Industrial Chain
Figure 60. Congestive Heart Failure (CHF) Treatment Devices Manufacturing Cost Structure
Figure 61. Channels of Distribution (Direct Sales, and Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Related Reports
Global Congestive Heart Failure (CHF) Treatment Devices Market Research Report 2024
Congestive heart failure (CHF) is a physiological condition that has an adverse impact on the pumping efficiency of the cardiac muscles. It characterizes the accumulation of fluid around the heart leading to inefficient pumping. The onset of CHF is marked by the failure of the ventricles to pump sufficient volume of blood to the body organs. This eventually leads to deposition of fluid in the lungs, abdomen, liver, and lower body. CHF is treated by a number of devices that maintain heart rhythm, such as pacemakers, cardiac resynchronization therapy (CRT), implantable cardioverter defibrillators (ICDs), and ventricular assist devices (VADs).
Published Date: 2024-01-16
Pages: 94
USD 2900.00
(Single User License)
Congestive Heart Failure (CHF) Treatment Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Congestive heart failure (CHF) is a physiological condition that has an adverse impact on the pumping efficiency of the cardiac muscles. It characterizes the accumulation of fluid around the heart leading to inefficient pumping. The onset of CHF is marked by the failure of the ventricles to pump sufficient volume of blood to the body organs. This eventually leads to deposition of fluid in the lungs, abdomen, liver, and lower body. CHF is treated by a number of devices that maintain heart rhythm, such as pacemakers, cardiac resynchronization therapy (CRT), implantable cardioverter defibrillators (ICDs), and ventricular assist devices (VADs).
Published Date: 2024-01-24
Pages: 123
USD 3950.00
(Single User License)
Global Congestive Heart Failure (CHF) Treatment Devices Market Insights, Forecast to 2030
Congestive heart failure (CHF) is a physiological condition that has an adverse impact on the pumping efficiency of the cardiac muscles. It characterizes the accumulation of fluid around the heart leading to inefficient pumping. The onset of CHF is marked by the failure of the ventricles to pump sufficient volume of blood to the body organs. This eventually leads to deposition of fluid in the lungs, abdomen, liver, and lower body. CHF is treated by a number of devices that maintain heart rhythm, such as pacemakers, cardiac resynchronization therapy (CRT), implantable cardioverter defibrillators (ICDs), and ventricular assist devices (VADs).
Published Date: 2024-04-12
Pages: 107
USD 4900.00
(Single User License)
Global Congestive Heart Failure (CHF) Treatment Devices Market Research Report 2025
The global market for Congestive Heart Failure (CHF) Treatment Devices was valued at US$ 5451 million in the year 2024 and is projected to reach a revised size of US$ 6730 million by 2031, growing at a CAGR of 3.1% during the forecast period.
Published Date: 2025-02-25
Pages: 86
USD 2900.00
(Single User License)
Congestive Heart Failure (CHF) Treatment Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Congestive Heart Failure (CHF) Treatment Devices was estimated to be worth US$ 5451 million in 2024 and is forecast to a readjusted size of US$ 6730 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published Date: 2025-02-25
Pages: 110
USD 3950.00
(Single User License)
Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Congestive Heart Failure (CHF) Treatment Devices market size was US$ 5451 million in 2024 and is forecast to a readjusted size of US$ 6730 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 78
USD 4250.00
(Single User License)
Global Congestive Heart Failure (CHF) Treatment Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Congestive Heart Failure (CHF) Treatment Devices market is projected to grow from US$ 5451 million in 2024 to US$ 6730 million by 2031, at a CAGR of 3.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-30
Pages: 132
USD 4900.00
(Single User License)
Global Congestive Heart Failure (CHF) Treatment Devices Market Research Report 2026
The global Congestive Heart Failure (CHF) Treatment Devices market was valued at US$ 5603 million in 2025 and is anticipated to reach US$ 6918 million by 2032, at a CAGR of 3.1% from 2026 to 2032.
Published Date: 2026-04-27
Pages: 115
USD 2900.00
(Single User License)
Global Congestive Heart Failure (CHF) Treatment Devices Market Research Report 2024
Congestive heart failure (CHF) is a physiological condition that has an adverse impact on the pumping efficiency of the cardiac muscles. It characterizes the accumulation of fluid around the heart leading to inefficient pumping. The onset of CHF is marked by the failure of the ventricles to pump sufficient volume of blood to the body organs. This eventually leads to deposition of fluid in the lungs, abdomen, liver, and lower body. CHF is treated by a number of devices that maintain heart rhythm, such as pacemakers, cardiac resynchronization therapy (CRT), implantable cardioverter defibrillators (ICDs), and ventricular assist devices (VADs).
Published: 2024-01-16
Pages: 94
USD 2900.00 (Single User License)Congestive Heart Failure (CHF) Treatment Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Congestive heart failure (CHF) is a physiological condition that has an adverse impact on the pumping efficiency of the cardiac muscles. It characterizes the accumulation of fluid around the heart leading to inefficient pumping. The onset of CHF is marked by the failure of the ventricles to pump sufficient volume of blood to the body organs. This eventually leads to deposition of fluid in the lungs, abdomen, liver, and lower body. CHF is treated by a number of devices that maintain heart rhythm, such as pacemakers, cardiac resynchronization therapy (CRT), implantable cardioverter defibrillators (ICDs), and ventricular assist devices (VADs).
Published: 2024-01-24
Pages: 123
USD 3950.00 (Single User License)Global Congestive Heart Failure (CHF) Treatment Devices Market Insights, Forecast to 2030
Congestive heart failure (CHF) is a physiological condition that has an adverse impact on the pumping efficiency of the cardiac muscles. It characterizes the accumulation of fluid around the heart leading to inefficient pumping. The onset of CHF is marked by the failure of the ventricles to pump sufficient volume of blood to the body organs. This eventually leads to deposition of fluid in the lungs, abdomen, liver, and lower body. CHF is treated by a number of devices that maintain heart rhythm, such as pacemakers, cardiac resynchronization therapy (CRT), implantable cardioverter defibrillators (ICDs), and ventricular assist devices (VADs).
Published: 2024-04-12
Pages: 107
USD 4900.00 (Single User License)Global Congestive Heart Failure (CHF) Treatment Devices Market Research Report 2025
The global market for Congestive Heart Failure (CHF) Treatment Devices was valued at US$ 5451 million in the year 2024 and is projected to reach a revised size of US$ 6730 million by 2031, growing at a CAGR of 3.1% during the forecast period.
Published: 2025-02-25
Pages: 86
USD 2900.00 (Single User License)Congestive Heart Failure (CHF) Treatment Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Congestive Heart Failure (CHF) Treatment Devices was estimated to be worth US$ 5451 million in 2024 and is forecast to a readjusted size of US$ 6730 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published: 2025-02-25
Pages: 110
USD 3950.00 (Single User License)Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Congestive Heart Failure (CHF) Treatment Devices market size was US$ 5451 million in 2024 and is forecast to a readjusted size of US$ 6730 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 78
USD 4250.00 (Single User License)Global Congestive Heart Failure (CHF) Treatment Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Congestive Heart Failure (CHF) Treatment Devices market is projected to grow from US$ 5451 million in 2024 to US$ 6730 million by 2031, at a CAGR of 3.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-30
Pages: 132
USD 4900.00 (Single User License)Global Congestive Heart Failure (CHF) Treatment Devices Market Research Report 2026
The global Congestive Heart Failure (CHF) Treatment Devices market was valued at US$ 5603 million in 2025 and is anticipated to reach US$ 6918 million by 2032, at a CAGR of 3.1% from 2026 to 2032.
Published: 2026-04-27
Pages: 115
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
Market Segmentation
Why This Report?
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
Interest In This Report?
Get A Free Sample
Pre-Order Enquiry
OR
Need a Tailored Report?
Customize this report to your needs.
Customize This Report
Fact Checked
Cite this Research